301 related articles for article (PubMed ID: 17949889)
1. Specific inhibition of basal mitogen-activated protein kinases and phosphatidylinositol 3 kinase activities in leukemia cells: a possible therapeutic role for the kinase inhibitors.
Champelovier P; El Atifi M; Pautre V; Rostaing B; Berger F; Seigneurin D
Exp Hematol; 2008 Jan; 36(1):28-36. PubMed ID: 17949889
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological inhibitors of the mitogen-activated protein kinase (MAPK) kinase/MAPK cascade interact synergistically with UCN-01 to induce mitochondrial dysfunction and apoptosis in human leukemia cells.
Dai Y; Yu C; Singh V; Tang L; Wang Z; McInistry R; Dent P; Grant S
Cancer Res; 2001 Jul; 61(13):5106-15. PubMed ID: 11431348
[TBL] [Abstract][Full Text] [Related]
3. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.
Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S
Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569
[TBL] [Abstract][Full Text] [Related]
4. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
5. Synergistic induction of apoptosis in human leukemia cells (U937) exposed to bryostatin 1 and the proteasome inhibitor lactacystin involves dysregulation of the PKC/MAPK cascade.
Vrana JA; Grant S
Blood; 2001 Apr; 97(7):2105-14. PubMed ID: 11264178
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
[TBL] [Abstract][Full Text] [Related]
7. Different signaling pathways are involved in cardiomyocyte survival induced by a Trypanosoma cruzi glycoprotein.
Aoki Mdel P; Cano RC; Pellegrini AV; Tanos T; Guiñazú NL; Coso OA; Gea S
Microbes Infect; 2006 Jun; 8(7):1723-31. PubMed ID: 16815723
[TBL] [Abstract][Full Text] [Related]
8. IGF-I stimulates IL-8 production in the promyelocytic cell line HL-60 through activation of extracellular signal-regulated protein kinase.
Kooijman R; Coppens A; Hooghe-Peters E
Cell Signal; 2003 Dec; 15(12):1091-8. PubMed ID: 14575864
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the PI3K pathway sensitizes fludarabine-induced apoptosis in human leukemic cells through an inactivation of MAPK-dependent pathway.
Yu C; Mao X; Li WX
Biochem Biophys Res Commun; 2005 Jun; 331(2):391-7. PubMed ID: 15850772
[TBL] [Abstract][Full Text] [Related]
10. Porphyromonas gingivalis-related cardiac cell apoptosis was majorly co-activated by p38 and extracellular signal-regulated kinase pathways.
Lee SD; Wu CC; Kuo WW; Lin JA; Hwang JM; Lu MC; Chen LM; Hsu HH; Wang CK; Chang SH; Huang CY
J Periodontal Res; 2006 Feb; 41(1):39-46. PubMed ID: 16409254
[TBL] [Abstract][Full Text] [Related]
11. Glucose-potentiated chemotaxis in human vascular smooth muscle is dependent on cross-talk between the PI3K and MAPK signaling pathways.
Campbell M; Allen WE; Sawyer C; Vanhaesebroeck B; Trimble ER
Circ Res; 2004 Aug; 95(4):380-8. PubMed ID: 15242975
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of PI-3 kinase sensitizes human leukemic cells to histone deacetylase inhibitor-mediated apoptosis through p44/42 MAP kinase inactivation and abrogation of p21(CIP1/WAF1) induction rather than AKT inhibition.
Rahmani M; Yu C; Reese E; Ahmed W; Hirsch K; Dent P; Grant S
Oncogene; 2003 Sep; 22(40):6231-42. PubMed ID: 13679862
[TBL] [Abstract][Full Text] [Related]
13. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
Liu Y; Chen X; Luo Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of extracellular signal-regulated kinase (ERK) mediates cell cycle phase independent apoptosis in vinblastine-treated ML-1 cells.
Stadheim TA; Xiao H; Eastman A
Cancer Res; 2001 Feb; 61(4):1533-40. PubMed ID: 11245462
[TBL] [Abstract][Full Text] [Related]
15. Reversal of boswellic acid analog BA145 induced caspase dependent apoptosis by PI3K inhibitor LY294002 and MEK inhibitor PD98059.
Pathania AS; Joshi A; Kumar S; Guru SK; Bhushan S; Sharma PR; Bhat WW; Saxena AK; Singh J; Shah BA; Andotra SS; Taneja SC; Malik FA; Kumar A
Apoptosis; 2013 Dec; 18(12):1561-73. PubMed ID: 23948751
[TBL] [Abstract][Full Text] [Related]
16. Involvement of histone H3 phosphorylation through p38 MAPK pathway activation in casticin-induced cytocidal effects against the human promyelocytic cell line HL-60.
Kikuchi H; Yuan B; Yuhara E; Takagi N; Toyoda H
Int J Oncol; 2013 Dec; 43(6):2046-56. PubMed ID: 24064676
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta1 transcriptionally activates CD34 and prevents induced differentiation of TF-1 cells in the absence of any cell-cycle effects.
Marone M; Scambia G; Bonanno G; Rutella S; de Ritis D; Guidi F; Leone G; Pierelli L
Leukemia; 2002 Jan; 16(1):94-105. PubMed ID: 11840268
[TBL] [Abstract][Full Text] [Related]
18. Sensitisation of HL60 human leukaemic cells to cytotoxic drug-induced apoptosis by inhibition of PI3-kinase survival signals.
O'Gorman DM; McKenna SL; McGahon AJ; Knox KA; Cotter TG
Leukemia; 2000 Apr; 14(4):602-11. PubMed ID: 10764145
[TBL] [Abstract][Full Text] [Related]
19. Beta-sitosterol-induced-apoptosis is mediated by the activation of ERK and the downregulation of Akt in MCA-102 murine fibrosarcoma cells.
Moon DO; Lee KJ; Choi YH; Kim GY
Int Immunopharmacol; 2007 Aug; 7(8):1044-53. PubMed ID: 17570321
[TBL] [Abstract][Full Text] [Related]
20. Activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway overcomes cisplatin resistance in ovarian carcinoma cells.
Nonaka M; Itamochi H; Kawaguchi W; Kudoh A; Sato S; Uegaki K; Naniwa J; Sato S; Shimada M; Oishi T; Terakawa N; Kigawa J; Harada T
Int J Gynecol Cancer; 2012 Jul; 22(6):922-9. PubMed ID: 22672985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
